Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today ...

SERA is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of SERA shares has decreased $0.05 since the market last closed. This is a 2.13% ...

2026 geographic target -- Sera Prognostics aims to reach 15–17 states encompassing 58%–60% of U.S. births and operate five to ...

Ever been stuck on the road far from home with a breakdown? Not fun. So imagine getting an email or text warning weeks or months before a starter quits, a battery dies or a fuel pump fails. Some of ...

Sera Prognostics Inc (NASDAQ:SERA) is set to release its Q4 2025 earnings on Mar 18, 2026. The consensus estimate for Q4 2025 revenue is $0.03 million, and the earnings are expected to come in at ...

The company targets active discussions in 15–17 states and aims to run 5–7 partner programs by the end of 2026, representing 58–60% of U.S. births. Aerts explained, "We have budgeted the same -- ...

DALLAS. Prognostics – being able to predict a component or part failure in advance – will be the true growth area in telematics in the coming decade, at least in North America and Europe, a leading ...

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, ...